All In Biotech

Drug Trial Radar · NCT07900919

OB VEGA-Phenylephrine vs Norepinephrine Outcomes

Last checked: Nov 19, 2026Latest source record: Oct 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruitingPivotal-lookingRandomized with 1,500 participants. This is a heuristic, not a regulatory label.

Status

Not yet recruiting

Enrollment

1,500

Planned (sponsor's estimate)

Start

Jan 2027

Primary completion

Dec 2027

Study completion Dec 2027

Sponsor

Lead sponsor
Wake Forest University Health SciencesAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Oct 28, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

OB VEGA-Phenylephrine vs Norepinephrine Outcomes evaluation

Conditions

  • Hypotension During Surgery
  • Cesarean Birth

Interventions

  • PhenylephrineDrug

    use of phenylephrine for hypotension intraoperatively during cesarean delivery

  • NorepinephrineDrug

    use of norepinephrine for hypotension intraoperatively during cesarean delivery

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Uterine tone-obstetrician evaluation scoresTime frame: up to 2 hours
  2. Change in Uterine tone-obstetrician evaluation scores with Uterine tone-uterotonic drug administrationTime frame: up to 2 hours
  3. Uterine tone-blood loss amountTime frame: hour 24
  4. Uterine tone-blood loss amount - Postoperative hemoglobin dropTime frame: hour 24

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Atrium Health-Wake Forest Baptist

    Winston-Salem, North Carolina

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.